tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
ImmunityBio (DE:26CA)
FRANKFURT:26CA
Germany Market
26CA
ImmunityBio
RESEARCH TOOLSreports

ImmunityBio (26CA) Stock News & Sentiment

Compare
15 Followers
Buy Rating on ANKTIVA: NCCN Guideline Expansion, Off‑Label Upside, and DCF‑Backed Risk‑Reward in BCG‑Unresponsive NMIBC
Premium
Ratings
Buy Rating on ANKTIVA: NCCN Guideline Expansion, Off‑Label Upside, and DCF‑Backed Risk‑Reward in BCG‑Unresponsive NMIBC
3d ago
IBRX
Expanding ANKTIVA’s NMIBC Opportunity: NCCN Endorsement, FDA Flexibility, and Strengthening Long‑Term Prospects for ImmunityBio
Premium
Ratings
Expanding ANKTIVA’s NMIBC Opportunity: NCCN Endorsement, FDA Flexibility, and Strengthening Long‑Term Prospects for ImmunityBio
4d ago
IBRX
Buy Rating on ImmunityBio Driven by ANKTIVA’s Rapid Commercial Ramp, Global Expansion, and Pipeline Catalysts
Premium
Ratings
Buy Rating on ImmunityBio Driven by ANKTIVA’s Rapid Commercial Ramp, Global Expansion, and Pipeline Catalysts
10d ago
IBRX
ImmunityBio Earnings Call: ANKTIVA Surge Amid High Burn
Premium
Company Announcements
ImmunityBio Earnings Call: ANKTIVA Surge Amid High Burn
11d ago
IBRX
ImmunityBio: Advancing ANKTIVA Into a Global, Multi-Indication Immunotherapy Platform Supporting a Buy Rating and $15 Target
Premium
Ratings
ImmunityBio: Advancing ANKTIVA Into a Global, Multi-Indication Immunotherapy Platform Supporting a Buy Rating and $15 Target
17d ago
IBRX
IBRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IBRX Earnings this Week: How Will it Perform?
20d ago
IBRX
ImmunityBio Wins EU Nod for ANKTIVA Bladder Cancer Therapy
Premium
Company Announcements
ImmunityBio Wins EU Nod for ANKTIVA Bladder Cancer Therapy
1M ago
8K
IBRX
More DE:26CA News >

26CA News on the Web

ImmunityBio announces approval in Macau for Anktiva
TipRanks News
Bullish
Mixed options sentiment in ImmunityBio with shares up 3.53%
TipRanks News
Neutral
ImmunityBio Stock Jumps on Big Cancer Breakthrough
TipRanks News
Bullish
Buy Rating on ANKTIVA: NCCN Guideline Expansion, Off‑Label Upside, and DCF‑Backed Risk‑Reward in BCG‑Unresponsive NMIBC
TipRanks News
Bullish
Expanding ANKTIVA’s NMIBC Opportunity: NCCN Endorsement, FDA Flexibility, and Strengthening Long‑Term Prospects for ImmunityBio
TipRanks News
Bullish
ImmunityBio (IBRX) Gains on Expanded Bladder Cancer Therapy Use
GuruFocus News
Bullish
Why ImmunityBio Stock Is Slumping Despite Drug Nod
TipRanks News
Neutral
Will Anktiva Continue to Drive ImmunityBio's Top-Line Growth in 2026?
Zacks
Bullish

News Score - Last 7 Days

Positive
DE:26CA
Sector Average
Media Buzz
This Week12 articles
Weekly Average13.75 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:26CA’s Media Buzz Sentiment?
12 articles about DE:26CA were published this week. In an average week, 13.75 articles are published.
    What is DE:26CA’s weekly average amount of articles?
    In an average week, 13.75 articles about DE:26CA are published.
      What is DE:26CA’s News Sentiment?
      100% of articles about DE:26CA were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        ABOSAcumen Pharmaceuticals
        KMTSKestra Medical Technologies Ltd.
        OVIDOvid Therapeutics
        MISTMilestone Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week